December 11, 2025 · Form 4 insider transaction
GSK plc bought 1,470,000 shares of WAVE LIFE SCIENCES LTD at $19.00 per share, a transaction worth $27.93M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").